Neuralgia Completed Phase 3 Trials for Pregabalin (DB00230)

Also known as: Neuralgia NOS

IndicationStatusPhase
DBCOND0017747 (Neuralgia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00141219Pregabalin Peripheral Neuropathic Pain StudyTreatment
NCT00150436To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia.Treatment
NCT00407745A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord InjuryTreatment
NCT00631943A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve PainTreatment
NCT01202227An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic PainTreatment